Total |
Avastin |
Herceptin |
Lucentis |
Nutropin |
Pulmozyme |
Raptiva |
Rituxan |
Tarceva |
Thrombolytics |
Xolair |
Other
Avastin U.S. Sales $ in millions
| |
Q1 |
Q2 |
Q3 |
Q4 |
Year Total |
|---|---|---|---|---|---|
| 2008 |
$ 600 |
$ 650 |
- |
- |
- |
| 2007 |
$ 533 |
$ 564 |
$ 597 |
$ 603 |
$ 2,296 |
| 2006 |
$ 398 |
$ 423 |
$ 435 |
$ 490 |
$ 1,746 |
| 2005 |
$ 202.9 |
$ 245.7 |
$ 325.2 |
$ 359.1 |
$ 1,132.9 |
| 2004 |
$ 38.1 |
$ 133.0 |
$ 183.0 |
$ 190.5 |
$ 544.6 |
Avastin Sales to Collaborators $
in millions
| |
Q1 |
Q2 |
Q3 |
Q4 |
Year Total |
|---|---|---|---|---|---|
| 2008 |
$ 11 |
$ 27 |
- |
- |
- |
| 2007 |
$ 58 |
$ 45 |
$ 39 |
$ 14 |
$ 157 |
| 2006 |
$ 18 |
$ 30 |
$ 21 |
$ 38 |
$ 107 |
| 2005 |
$ 11.6 |
$ 3.6 |
$ 20.6 |
$ 13.8 |
$ 49.6 |
| 2004 |
- |
- |
- |
$ 9.9 |
$ 9.9 |
Avastin Sales Total $ in millions
| |
Q1 |
Q2 |
Q3 |
Q4 |
Year Total |
|---|---|---|---|---|---|
| 2008 |
$ 611 |
$ 677 |
- |
- |
- |
| 2007 |
$ 591 |
$ 609 |
$ 637 |
$ 617 |
$ 2,453 |
| 2006 |
$ 416 |
$ 453 |
$ 456 |
$ 527 |
$ 1,853 |
| 2005 |
$ 214.5 |
$ 249.3 |
$ 345.8 |
$ 372.9 |
$ 1,182.5 |
| 2004 |
$ 38.1 |
$ 133.0 |
$ 183.0 |
$ 200.4 |
$ 554.5 |
In 2006 the values shown above are exact, which may lead to the appearance of footing errors.
Numbers may reflect rounding adjustments.